VIR BIOTECHNOLOGY INC (VIR)
US92764N1028 - Common Stock
ChartMill assigns a Buy % Consensus number of 77% to VIR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 32.93. This target is 293.45% above the current price.
VIR was analyzed by 13 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about VIR.
In the previous month the buy percentage consensus was at a similar level.
VIR was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-23 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-02-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-01-29 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-01-23 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-03 | Needham | Maintains | Buy -> Buy |
| 2023-09-08 | B of A Securities | Downgrade | Buy -> Neutral |
| 2023-08-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-04 | Needham | Reiterate | Buy -> Buy |
| 2023-07-21 | Barclays | Maintains | Overweight -> Overweight |
| 2023-07-21 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-07-21 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-07-20 | Needham | Maintains | Buy -> Buy |
| 2023-07-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-05 | Needham | Reiterate | Buy |
| 2023-04-19 | Needham | Reiterate | Buy |
| 2023-04-04 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-03-06 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2023-03-06 | HC Wainwright & Co. | Maintains | Buy |
| 2023-02-24 | Needham | Reiterate | Buy |
| 2023-02-23 | Goldman Sachs | Maintains | Buy |
| 2023-02-21 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2023-01-27 | SVB Leerink | Maintains | Outperform |
| 2023-01-27 | Morgan Stanley | Upgrade | Underweight -> Equal-Weight |
| 2022-11-04 | Needham | Maintains | Buy |
| 2022-11-04 | SVB Leerink | Maintains | Outperform |
| 2022-11-04 | Morgan Stanley | Maintains | Underweight |
| 2022-09-14 | SVB Leerink | Initiate | Outperform |
| 2022-09-09 | Morgan Stanley | Initiate | Underweight |
| 2022-05-12 | HC Wainwright & Co. | Maintains | Buy |